Northrop Grumman stock gains on $4.8 billion Army countermeasure contract and fresh UBS upgrade

Published on 09/09/2026 at 14:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Northrop Grumman stock is supported by a new $4.84 billion Army infrared countermeasure production contract awarded on September 8, 2026. UBS also reaffirmed its Buy rating and lifted its price target to USD 704, adding an analyst tailwind for investors.

Militärjet und Radarturm auf Wüstenflugplatz bei Sonnenuntergang — Northrop Grumman US6668071029 zeigt generischen Militärjet neben Radaranlage bei Sonnenuntergang auf Wüstenflugplatz, Illustration mit AI erstellt.

Northrop Grumman stock (ISIN US6668071029) is drawing investor attention after the U.S. Army awarded the defense group a firm-fixed-price contract worth about USD 4.84 billion for full-rate production of its Common Infrared Countermeasure system, with work expected to run through September 2035 as announced on September 8, 2026.ClearanceJobs In parallel, UBS maintained its Buy rating on Northrop Grumman and raised its price target to USD 704 on September 8, 2026, providing an analyst endorsement of the shares.Benzinga

Army awards multi-billion dollar countermeasure contract

According to ClearanceJobs on September 8, 2026, Northrop Grumman Systems Corp. in Rolling Meadows, Illinois, was awarded a USD 4,838,487,318 firm-fixed-price, indefinite-delivery and indefinite-quantity contract for full rate production of the Common Infrared Countermeasure system. The contract runs with an estimated completion date of September 30, 2035, positioning the program as a long-term revenue contributor over nearly nine years. Work locations and funding will be determined with each order, giving the company flexibility in deployment while locking in a sizable backlog.

The Common Infrared Countermeasure system is designed to protect aircraft from heat-seeking missiles, and the full-rate production decision indicates that the Army is moving beyond low-rate initial production into sustained deployment, which typically supports more predictable manufacturing volumes. For investors, the roughly USD 4.84 billion contract value compares with single-program awards that often run in the hundreds of millions of dollars, underscoring the strategic weight of this mandate in Northrop Grumman's portfolio.ClearanceJobs

Analyst upgrade and valuation context

As Benzinga reported on September 8, 2026, UBS reiterated its Buy rating on Northrop Grumman and lifted its price target to USD 704, signaling greater upside potential than previously assumed. Although the prior target is not specified in the available summary, the new figure sits meaningfully above recent share prices cited by valuation platforms, implying double-digit upside in UBS's view if execution on major programs such as the Common Infrared Countermeasure and advanced aircraft platforms continues as planned.

On the valuation side, GuruFocus noted on September 8, 2026, that Northrop Grumman shares were trading at USD 518.58, which the platform estimates to be approximately 8.1% below its GF Value of USD 564.39. That gap indicates modest upside based on its intrinsic value model and reinforces UBS's constructive stance. The same analysis highlights a trailing price-to-earnings ratio of 16.49 times, very close to the company's five-year median P/E of 16.58 times, suggesting that the stock is valued in line with its historical earnings multiple rather than at an extreme premium or discount.GuruFocus

In the same September 8, 2026 valuation overview, GuruFocus assigns Northrop Grumman a GF Score of 84 out of 100, reflecting strong overall fundamentals and business quality. The company offers a dividend yield of 1.84% backed by a payout ratio of 30% and a dividend growth rate of around 10% over the past three years, indicating that returns to shareholders are supported by earnings and cash flow rather than aggressive leverage. For income-focused investors, this profile shows that the shares combine defense exposure with a steadily growing dividend, even as major contracts expand the backlog.

Fundamental performance and dividend profile

Although detailed quarterly figures for 2026 are not fully summarized in the latest hits, the valuation snapshot from GuruFocus on September 8, 2026 indicates that Northrop Grumman's trailing earnings support a P/E of 16.49 times, in line with its historical median of 16.58 times. This stability in the earnings multiple signals that the market is treating recent profit trends as broadly consistent with the past five years, even as the company secures new multi-billion dollar contracts. The modest undervaluation relative to the GF Value estimate of USD 564.39 suggests that, on this model, earnings and cash flows justify a somewhat higher share price than the quoted USD 518.58 level at that time.

The same overview emphasizes the strength of Northrop Grumman's dividend track record. With a dividend yield of 1.84% and a payout ratio of 30%, the company retains a substantial portion of its earnings to reinvest in major defense programs while still returning cash to shareholders.GuruFocus A roughly 10% dividend growth rate over the past three years further underlines management's commitment to steadily increasing distributions as profits expand. For investors, the combination of new long-duration contracts like the Common Infrared Countermeasure award and a conservative dividend policy can be attractive, as it pairs predictable program revenues with disciplined capital allocation.

Sector backdrop and competitive context

The timing of the Army's Common Infrared Countermeasure award coincides with broader activity in advanced defense platforms. On September 8, 2026, the Pentagon was expected to announce its decision on the Navy's next-generation F/A-XX stealth fighter contract, with Boeing and Northrop Grumman among the leading contenders.GuruFocus While the F/A-XX decision itself is separate from the infrared countermeasure program, Northrop Grumman's role as a leading contender for major aircraft work illustrates its broader positioning in U.S. defense modernization efforts. The mix of electronic warfare, countermeasures and advanced air platforms forms a key strategic cluster for the company.

In parallel, broader commentary on defense stocks notes that a majority of analysts covering Northrop Grumman maintain positive ratings. A recent overview cites a Buy rating ratio of around 61% for Northrop Grumman among its coverage universe, compared with 60% for L3Harris and 46% for Lockheed Martin, highlighting relatively strong consensus support within the peer group.MSN For investors comparing defense names, this suggests that Northrop Grumman sits toward the upper end of analyst conviction, supported by its exposure to long-term U.S. defense priorities.

Stock price level and investor perspective

As of September 8, 2026, valuation data from GuruFocus shows Northrop Grumman trading at USD 518.58 on the New York Stock Exchange, about 8.1% below the platform's GF Value estimate of USD 564.39. This places the shares in a valuation band that is neither deeply discounted nor stretched, but with a measurable gap to intrinsic value and additional upside implied by UBS's higher USD 704 price target. For investors, the key question is whether major contracts like the USD 4.84 billion Common Infrared Countermeasure program and potential awards in next-generation aircraft can translate into sustained earnings growth that closes this gap.